In light of the above evidence, we aimed to investigate the extent of the potential genetic sharing and contribution of insulin-related gene sets in the observed comorbidity of neuropsychiatric disorders having preclinical evidence of insulin signalling dysregulation (i.e., AD, ASD, and OCD) with somatic diseases related to insulin resistance, namely MetS, obesity, and T2DM. This evidence concerns the gene INS and Obesity.